Kyle R. Kline serves as Senior Vice President and Chief Financial Officer at Globus Medical Inc., a leading developer and manufacturer of musculoskeletal medical devices. In this pivotal role, which he assumed in December 2021 after joining the company in October 2014 as Vice President of Finance, Kline oversees all aspects of the company's financial operations. This includes strategic financial planning, reporting, treasury management, tax strategy, risk management, and investor relations, playing a key role in supporting Globus Medical's innovation-driven growth and global expansion in spine, orthopedics, and enabling technologies. Prior to Globus Medical, Kline was Director of Finance at NuVasive, Inc., from 2012 to 2014, where he led financial planning and analysis amid the company's rapid market expansion. His earlier career featured seven years as a Senior Manager in KPMG LLP's audit practice, specializing in healthcare and life sciences clients, as well as positions at Susquehanna International Group, LLP, and PricewaterhouseCoopers LLP. These roles equipped him with deep expertise in financial auditing, compliance, and strategic advisory services across complex industries. Kline's leadership has been instrumental in Globus Medical's major achievements, including the landmark 2023 merger with NuVasive, which created a premier musculoskeletal technology company with enhanced scale and capabilities. Under his guidance, the firm has achieved strong revenue growth, operational efficiencies, and shareholder value creation, while maintaining financial discipline to fuel R&D investments and advance transformative solutions for patients worldwide.